Article: Cypher stent featured in more than 25 studies at the AHA meeting.

2004 DEC 7 - (NewsRx.com & NewsRx.net) -- Clinical data regarding the use of the Cypher Sirolimus-eluting Coronary Stent in treating challenging coronary lesions in a variety of patient populations were presented at the 2004 American Heart Association Scientific Sessions in New Orleans, Louisiana.

The Cypher Stent remains the most studied drug-eluting stent available today.

Among the more than 25 key Cypher Stent presentations at the international medical conference are results from the robust, international e-Cypher registry, which tracks use of the device in more than 15,000 patients; and studies that evaluate the Cypher Stent's performance in complex ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!